// App-Quantinova.ai

122 : Etanercept-Methotrexate Combination Therapy Compared with Etanercept Monotherapy in Rheumatoid Arthritis Patients with Moderate or Severe Disease in the CAMEO Trial

Researchers

Presenter

  • Boulos Haraoui

Principal Investigators

  • Carter Thorne

  • Melanie Poulin-Costello

  • Eric Trottier

  • Andrew Vieira

  • Janet Pope

Medical Centers

  • Mount Sinai Hospital, Toronto, ON, Canada

  • Mississauga,Canada

  • University of Western Ontario, London, ON, Canada

Locations

  • Canada

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Malondialdehyde

  • Tumor necrosis factor

Drug/Treatment

  • Methotrexate

  • Etanercept

  • CHS-0214

Outcome

  • Unknown

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved